Mj. Petruzzi et Pa. Dealarcon, NEUROBLASTOMA-ASSOCIATED OPSOCLONAS-MYOCLONUS TREATED WITH INTRAVENOUSLY ADMINISTERED IMMUNE GLOBULIN-G, The Journal of pediatrics, 127(2), 1995, pp. 328-329
An 18-month-old black girl had progressive truncal ataxia, opsoclonus,
and multifocal myoclonus associated with a nonresectable abdominal ga
nglioneuroblastoma, Before chemotherapy, she received intravenously ad
ministered IgG, 1 gm/kg, for 2 days; within 48 hours of the first dose
, there was significant improvement of the opsoclonus-myoclonus and at
axia, She required a 1 gm/kg maintenance dose every 4 to 6 weeks for a
total of 12 doses, but is now free of symptomatic after 2 years with
no therapy.